Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.89
-0.38 (-3.70%)
Mar 9, 2026, 3:04 PM EDT - Market open
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $2.15 billion as of March 9, 2026. Its market cap has increased by 88.89% in one year.
Market Cap
2.15B
Enterprise Value
1.48B
1-Year Change
88.89%
Ranking
Category
Stock Price
$9.89
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $2.15B, an increase of 695.92%. That is a compound annual growth rate of 19.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.24B | -13.56% |
| Dec 31, 2025 | 2.59B | 92.64% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 2.42B |
| Immunome | 2.38B |
| Disc Medicine | 2.33B |
| Adaptive Biotechnologies | 2.29B |
| Day One Biopharmaceuticals | 2.19B |
| Zai Lab | 2.19B |
| Maze Therapeutics | 2.16B |
| Galapagos NV | 2.15B |